E624 CMAJ| MAY 1, 2017| VOLUME 189| ISSUE 17 (forced vital capacity 40%–80%
predicted). The treatment may also be used in patients with severe skin involvement alone …

Systemic sclerosis is a chronic autoimmune disease with a poor prognosis, particularly
when a patient has rapidly progressive skin or pulmonary involvement. Autologous …

Systemic sclerosis is a chronic multisystem, autoimmune disease with high mortality, and to
date, has no effective approved therapy. For patients with the most severe forms of systemic …

Systemic sclerosis is a progressive inflammatory disease that is frequently fatal and has
limited treatment options. High-dose chemotherapy with autologous hematopoietic cell …

Autologous hematopoietic stem cell transplantation (AHSCT) has been proposed as a
therapeutic modality for severe systemic sclerosis (SSc). We set out to systematically review …

Background Non-randomised studies of haemopoietic stem-cell transplantation (HSCT) in
systemic sclerosis have shown improvements in lung function and skin flexibility but high …

Hematopoietic stem-cell transplantation in systemic sclerosi... : Current Opinion in
Rheumatology Hematopoietic stem-cell transplantation in systemic sclerosis: an update …

Systemic sclerosis (SSc) is a disease associated with a significant morbidity and mortality,
with relatively small benefits seen with immunosuppression. Of late, hematopoietic stem cell …

Objectives We aimed to evaluate the efficacy and safety of haematopoietic stem cell
transplantation (HSCT) in patients with systemic sclerosis. Methods A systematic literature …

Systemic sclerosis is a life-threatening disease that includes a subset of patients with diffuse
cutaneous systemic sclerosis (defined as widespread skin involvement) and internal organ …